{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:38:40Z","timestamp":1792539520834,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14069-w","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:35:05Z","timestamp":1784882105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changes in the microbial spectrum and antimicrobial resistance of bloodstream infections in intensive care units before and during the COVID-19 pandemic"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-2057","authenticated-orcid":false,"given":"S\u00fcmeyye","family":"Bayram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7387-5057","authenticated-orcid":false,"given":"Funda","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0050-3225","authenticated-orcid":false,"given":"\u00c7i\u011fdem","family":"Arabac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-9800","authenticated-orcid":false,"given":"Zekeriya","family":"Ervatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"14069_CR1","doi-asserted-by":"publisher","unstructured":"Song Y, Neff M, Gyarmati P. Challenges and advances in the diagnosis of bloodstream infection. Future Microbiol. 2022;17. https:\/\/doi.org\/10.2217\/fmb-2021-0304.","DOI":"10.2217\/fmb-2021-0304"},{"key":"14069_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501\u20139. https:\/\/doi.org\/10.1111\/1469-0691.12195.","journal-title":"Clin Microbiol Infect"},{"key":"14069_CR3","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/S0140-6736(24)00878-X","volume":"403","author":"R Laxminarayan","year":"2024","unstructured":"Laxminarayan R, Impalli I, Rangarajan R, Cohn J, Ramjeet K, Trainor BW, et al. Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance. Lancet. 2024;403:2534\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(24)00878-X.","journal-title":"Lancet"},{"key":"14069_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"14069_CR5","doi-asserted-by":"publisher","first-page":"e038300","DOI":"10.1136\/BMJOPEN-2020-038300","volume":"10","author":"N Daneman","year":"2020","unstructured":"Daneman N, Rishu AH, Pinto RL, Arabi YM, Cook DJ, Hall R, et al. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: study protocol. BMJ Open. 2020;10:e038300. https:\/\/doi.org\/10.1136\/BMJOPEN-2020-038300.","journal-title":"BMJ Open"},{"key":"14069_CR6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ajic.2020.01.009","volume":"48","author":"A Despotovic","year":"2020","unstructured":"Despotovic A, Milosevic B, Milosevic I, Mitrovic N, Cirkovic A, Jovanovic S, et al. Hospital-acquired infections in the adult intensive care unit\u2014Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality. Am J Infect Control. 2020;48:1211\u20135. https:\/\/doi.org\/10.1016\/j.ajic.2020.01.009.","journal-title":"Am J Infect Control"},{"key":"14069_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/S00134-019-05520-5","volume":"45","author":"JF Timsit","year":"2019","unstructured":"Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med 2019. 2019;45:2. https:\/\/doi.org\/10.1007\/S00134-019-05520-5.","journal-title":"Intensive Care Med 2019"},{"key":"14069_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ICE.2020.211","volume":"41","author":"C Rhee","year":"2020","unstructured":"Rhee C, Baker MA, Klompas M. The COVID-19 infection control arms race. Infect Control Hosp Epidemiol. 2020;41:1. https:\/\/doi.org\/10.1017\/ICE.2020.211.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"14069_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/J.AJIC.2020.10.019","volume":"49","author":"LEI Wee","year":"2020","unstructured":"Wee LEI, Conceicao EP, Tan JY, Magesparan KD, Amin IBM, Ismail BBS, et al. Unintended consequences of infection prevention and control measures during COVID-19 pandemic. Am J Infect Control. 2020;49:469. https:\/\/doi.org\/10.1016\/J.AJIC.2020.10.019.","journal-title":"Am J Infect Control"},{"key":"14069_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1086\/422641","volume":"39","author":"FHY Yap","year":"2004","unstructured":"Yap FHY, Gomersall CD, Fung KSC, Ho PL, Ho OM, Lam PKN, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis. 2004;39:511\u20136. https:\/\/doi.org\/10.1086\/422641.","journal-title":"Clin Infect Dis"},{"key":"14069_CR11","doi-asserted-by":"publisher","first-page":"106324","DOI":"10.1016\/J.IJANTIMICAG.2021.106324","volume":"57","author":"CC Lai","year":"2021","unstructured":"Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57:106324. https:\/\/doi.org\/10.1016\/J.IJANTIMICAG.2021.106324.","journal-title":"Int J Antimicrob Agents"},{"key":"14069_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/S00134-021-06346-W","volume":"47","author":"N Buetti","year":"2021","unstructured":"Buetti N, Ruckly S, de Montmollin E, Reignier J, Terzi N, Cohen Y, et al. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case\u2013cohort study from the multicentric OUTCOMEREA network. Intensive Care Med. 2021;47:180. https:\/\/doi.org\/10.1007\/S00134-021-06346-W.","journal-title":"Intensive Care Med"},{"key":"14069_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/ANTIBIOTICS11081053","volume":"11","author":"K Mantzarlis","year":"2022","unstructured":"Mantzarlis K, Deskata K, Papaspyrou D, Leontopoulou V, Tsolaki V, Zakynthinos E, et al. Incidence and Risk Factors for Blood Stream Infection in Mechanically Ventilated COVID-19 Patients. Antibiotics. 2022;11:1053. https:\/\/doi.org\/10.3390\/ANTIBIOTICS11081053.","journal-title":"Antibiotics"},{"key":"14069_CR14","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1097\/CCM.0000000000004748","volume":"49","author":"C Bonazzetti","year":"2021","unstructured":"Bonazzetti C, Morena V, Giacomelli A, Oreni L, Casalini G, Galimberti LR, et al. Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study. Crit Care Med. 2021;49:E31\u201340. https:\/\/doi.org\/10.1097\/CCM.0000000000004748.","journal-title":"Crit Care Med"},{"key":"14069_CR15","doi-asserted-by":"publisher","unstructured":"Waterlow NR, Cooper BS, Robotham JV, Knight GM. Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: an observational study. PLoS Med. 2024;21. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1004301.","DOI":"10.1371\/JOURNAL.PMED.1004301"},{"key":"14069_CR16","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.cmi.2023.10.019","volume":"30","author":"MD Pezzani","year":"2024","unstructured":"Pezzani MD, Arieti F, Rajendran NB, Barana B, Cappelli E, De Rui ME, et al. Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review. Clin Microbiol Infect. 2024;30:S4\u201313. https:\/\/doi.org\/10.1016\/j.cmi.2023.10.019.","journal-title":"Clin Microbiol Infect"},{"key":"14069_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/J.JOINTM.2023.12.004","volume":"4","author":"F Ntziora","year":"2024","unstructured":"Ntziora F, Giannitsioti E. Bloodstream infections in the era of the COVID-19 pandemic: Changing epidemiology of antimicrobial resistance in the intensive care unit. J Intensive Med. 2024;4:269. https:\/\/doi.org\/10.1016\/J.JOINTM.2023.12.004.","journal-title":"J Intensive Med"},{"key":"14069_CR18","unstructured":"Centers for Disease Control and Prevention (CDC). Primary measure: blood culture contamination rate. CDC Laboratory Quality. 2024. Available from: https:\/\/www.cdc.gov\/lab-quality\/php\/prevent-adult-blood-culture-contamination\/primary-measure.html. [Accessed January 8, 2026]."},{"key":"14069_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x.","journal-title":"Clin Microbiol Infect"},{"key":"14069_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/J.JHIN.2020.11.009","volume":"107","author":"S Kokkoris","year":"2020","unstructured":"Kokkoris S, Papachatzakis I, Gavrielatou E, Ntaidou T, Ischaki E, Malachias S, et al. ICU-acquired bloodstream infections in critically ill patients with COVID-19. J Hosp Infect. 2020;107:95. https:\/\/doi.org\/10.1016\/J.JHIN.2020.11.009.","journal-title":"J Hosp Infect"},{"key":"14069_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/23744235.2020.1802062","volume":"52","author":"AL Engsbro","year":"2020","unstructured":"Engsbro AL, Israelsen SB, Pedersen M, Tingsgaard S, Lisby G, Andersen C, et al. Predominance of hospital-acquired bloodstream infection in patients with Covid-19 pneumonia. Infect Dis. 2020;52:919\u201322. https:\/\/doi.org\/10.1080\/23744235.2020.1802062;SUBPAGE:STRING:ACCESS.","journal-title":"Infect Dis"},{"key":"14069_CR22","doi-asserted-by":"publisher","first-page":"2200845","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200845","volume":"27","author":"P Kinross","year":"2022","unstructured":"Kinross P, Gagliotti C, Merk H, Plachouras D, Monnet DL, H\u00f6gberg LD, et al. Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU\/EEA, 2020 and 2021. Eurosurveillance. 2022;27:2200845. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.46.2200845.","journal-title":"Eurosurveillance"},{"key":"14069_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/S15010-023-02000-3","volume":"51","author":"FV Segala","year":"2023","unstructured":"Segala FV, Pafundi PC, Masciocchi C, Fiori B, Taddei E, Antenucci L, et al. Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study. Infection. 2023;51:1061\u20139. https:\/\/doi.org\/10.1007\/S15010-023-02000-3.","journal-title":"Infection"},{"key":"14069_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/J.JHIN.2020.06.027","volume":"105","author":"A Sturdy","year":"2020","unstructured":"Sturdy A, Basarab M, Cotter M, Hager K, Shakespeare D, Shah N, et al. Severe COVID-19 and healthcare-associated infections on the ICU: time to remember the basics? J Hosp Infect. 2020;105:593. https:\/\/doi.org\/10.1016\/J.JHIN.2020.06.027.","journal-title":"J Hosp Infect"},{"key":"14069_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/LIFE11100996\/S1","volume":"11","author":"M Polemis","year":"2021","unstructured":"Polemis M, Mandilara G, Pappa O, Argyropoulou A, Perivolioti E, Koudoumnakis N, et al. COVID-19 and antimicrobial resistance: data from the greek electronic system for the surveillance of antimicrobial resistance\u2014WHONET-Greece (January 2018\u2013March 2021). Life. 2021;11:996. https:\/\/doi.org\/10.3390\/LIFE11100996\/S1.","journal-title":"Life"},{"key":"14069_CR26","doi-asserted-by":"publisher","first-page":"Doc35","DOI":"10.3205\/DGKH000370","volume":"15","author":"H Mahmoudi","year":"2020","unstructured":"Mahmoudi H. Bacterial co-infections and antibiotic resistance in patients with COVID-19. GMS Hyg Infect Control. 2020;15:Doc35. https:\/\/doi.org\/10.3205\/DGKH000370.","journal-title":"GMS Hyg Infect Control"},{"key":"14069_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/ANTIBIOTICS12020312","volume":"12","author":"DA Toc","year":"2023","unstructured":"Toc DA, Botan A, Botescu AMC, Brata VD, Colosi IA, Costache C, et al. A Tale of Two Pandemics: Antimicrobial Resistance Patterns of Enterococcus spp. in COVID-19 Era. Antibiotics. 2023;12:312. https:\/\/doi.org\/10.3390\/ANTIBIOTICS12020312.","journal-title":"Antibiotics"},{"key":"14069_CR28","doi-asserted-by":"publisher","first-page":"E533","DOI":"10.1093\/CID\/CIAA1239","volume":"72","author":"VM Vaughn","year":"2021","unstructured":"Vaughn VM, Gandhi TN, Petty LA, Patel PK, Prescott HC, Malani AN, et al. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study. Clin Infect Dis. 2021;72:E533\u201341. https:\/\/doi.org\/10.1093\/CID\/CIAA1239.","journal-title":"Clin Infect Dis"},{"key":"14069_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/J.CMI.2021.11.008","volume":"28","author":"BJ Langford","year":"2021","unstructured":"Langford BJ, So M, Leung V, Raybardhan S, Lo J, Kan T, et al. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. Clin Microbiol Infect. 2021;28:491. https:\/\/doi.org\/10.1016\/J.CMI.2021.11.008.","journal-title":"Clin Microbiol Infect"},{"key":"14069_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/S12879-022-07810-8","volume":"22","author":"KA Bauer","year":"2022","unstructured":"Bauer KA, Puzniak LA, Yu KC, Finelli L, Moise P, Ai CE, et al. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation. BMC Infect Dis. 2022;22:841. https:\/\/doi.org\/10.1186\/S12879-022-07810-8.","journal-title":"BMC Infect Dis"},{"key":"14069_CR31","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/J.CMI.2021.06.041","volume":"27","author":"G Abelenda-Alonso","year":"2021","unstructured":"Abelenda-Alonso G, Rombauts A, Gudiol C, Oriol I, Simonetti A, Coloma A, et al. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case\u2013control matched multicentre study (BACTCOVID). Clin Microbiol Infect. 2021;27:1685. https:\/\/doi.org\/10.1016\/J.CMI.2021.06.041.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14069-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14069-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14069-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:48:53Z","timestamp":1792536533000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14069-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14069"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14069-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Clinical Research Ethics Committee of the University of Health Sciences Prof. Dr. Cemil Ta\u015fc\u0131o\u011flu City Hospital, Istanbul, T\u00fcrkiye (decision no. 126) at its meeting held on 09 May 2022 (E-48670771-514.99). The requirement for informed consent was waived by the Clinical Research Ethics Committee of the University of Health Sciences Prof. Dr. Cemil Ta\u015fc\u0131o\u011flu City Hospital, Istanbul, T\u00fcrkiye, due to the retrospective nature of the study and the use of anonymized data. The study was performed in accordance with the ethical standards of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1846"}}